Hi Vaughn - The recent "news" about COX2 inhibitors came out at the same time as the spate of articles about Pennsaid.
None of this was news to Dimethaid investors, who have long waited to see Pennsaid distinguished from other topical NSAIDs, and have long been aware of the side-effects of pills, both NSAIDs and COX2 inhibitors.
The inability to fund trials sufficient to attain FDA approval now leaves us in a peculiar position: Americans can read about Pennsaid's superiority, but they can't buy it.
"If he makes the importation of drugs from Canada legal as he has promised to do, does that make advertizing Dimethaid in the US illegal even though it may only be purchased through CDN pharmacies until approved by the FDA?"
You raise an interesting point. Most of us see advertising a product as an implicit "offer to sell".
Without FDA approval, selling (or buying) in the States would be illegal, no matter what the President says. Importing (after buying in Canada) would also be illegal.
In theory, advertising that merely extolls Pennsaid's benefits could be done, but without legal product to sell, one doubts that consumers would be impressed. When there's nowhere to buy, and importation is illegal, any gains from advertising in the States would be marginal: perhaps more of an irritant than a benefit.
There's no way around it: we really need FDA approval.
Have you visited the American arthritis chat lines? They're asking about Pennsaid. It's reminiscent of "Maureen" on the UK arthritis chat lines, trying to get some Pennsaid years ago.
Sorry folks, we'd like to help, but blockhead "thinking" and years of cash starvation left us in this strange situation: we've got the product, and it works great. We know you want it, we know you'd buy it, but no, you can't have it.
Jim |
